Jennifer K. Pope
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.
Journal: Genome medicine
Published: July 29, 2025
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
Journal: BJU international
Published: June 05, 2024
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Journal: The Lancet. Oncology
Published: July 02, 2021
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
Journal: Journal of medical genetics
Published: June 27, 2019
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Journal: BJU international
Published: May 27, 2018
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
Journal: British journal of cancer
Published: November 21, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026